METTL3 and endometrial cancer: METTL3 was shown to inhibit cellular proliferation in endometrial cancer, as METTL3-mediated m6A promoted the translation of PHLPP2, a negative regulator of pro-proliferative AKT signaling (Liu et al., 2018).